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Expression of smooth muscle myosin 
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single smooth muscle cells 
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Abstract 
The functional significance of the variable expression of the smooth muscle myosin heavy chain 
(SM-MHC) tail isoforms, SM1 and SM2, was examined at the mRNA level (which correlates with 
the protein level) in individual permeabilized rabbit arterial smooth muscle cells (SMCs). The 
length of untethered single permeabilized SMCs was monitored during unloaded shortening in 
response to increased Ca2+ (pCa 6.0), histamine (1 μM), and phenylephrine (1 μM). Subsequent 
to contraction, the relative expression of SM1 and SM2 mRNAs from the same individual SMCs 
was determined by reverse transcription-polymerase chain reaction amplification and 
densitometric analysis. Correlational analyses between the SM2-to-SM1 ratio and unloaded 
shortening in saponin- and α-toxin-permeabilized SMCs (n = 28) reveal no significant 
relationship between the SM-MHC tail isoform ratio and unloaded shortening velocity. The best 
correlations between SM2/SM1 and the contraction characteristics of untethered vascular 
SMCs were with the minimum length attained following contraction (n = 20 andr = 0.72 for α-
toxin,n = 8 andr = 0.78 for saponin). These results suggest that the primary effect of variable 
expression of the SM1 and SM2 SM-MHC tail isoforms is on the cell final length and not on 
shortening velocity. 
 
The first pair of mammalian smooth muscle myosin heavy chain (SM-MHC) isoforms, identified 
by differential mobility using polyacrylamide gel electrophoresis, was named SM1 and SM2.29 
The difference between SM1 and SM2 SM-MHC isoforms has been localized to the 3′ nonhelical 
tail region of the myosin molecule.8, 27 It has been reported that one of the SM-MHC isoforms 
(SM1) has a 3′ nonhelical tail similar to nonmuscle, embryonic, and invertebrate myosins, 
whereas the other (SM2) exhibits a truncated tail.2, 27, 30, 40 The 3′ terminus of the MHC rod 
domain is critical to the nucleation process in myosin filament formation.6, 15, 32 MHC isoforms 
that exhibit nonhelical 3′ tails have been shown to have one or more conserved 
phosphorylatable serine residue(s) in this region.18, 19, 26 The phosphorylation state of the 3′ tail 
site(s) has also been shown to influence filament formation and length.6a, 17–19, 21–23 The relative 
influence of the unphosphorylated SM1 nonhelical tail or the absence of nonhelical tail in SM2 
on myosin filament assembly is not known. 
Attempts to define the unique physiological functions for the SM-MHC 3′ tail isoforms, SM1 and 
SM2, have generated conflicting results. Mechanical studies performed on multicellular smooth 
muscle samples from various tissues under a variety of conditions have shown that SM1 levels 
correlate with small increases in the maximal velocity of muscle shortening (Vmax),14,35 
decreases in force per unit weight,39 increases in Ca2+ sensitivity, and a decrease in unloaded 
shortening velocity.5 Morano et al.25 have reported a lack of correlation between the 
expression of either SM-MHC isoform, SM1 or SM2, andVmax in the same tissue used by 
Sparrow et al.35 and Hewett et al.14 In vitro studies of molecular myosins have described 
hydrolytic and mechanical differences between the α- and β-cardiac MHC isoforms.36 However, 
SM1 and SM2 are indistinguishable from one another with respect to their ability to move actin 
filaments using the in vitro motility assay.20 Clearly, the relationship between the contractile 
properties of smooth muscles and their SM-MHC complement has not been determined. 
One possible explanation for the discrepancy in these results is the fact that these mechanical 
studies were performed on tissue strips or purified proteins that were then assayed outside of 
their native three-dimensional organization. Several studies have reported differential 
expression of MHC isoforms among cells within the same smooth muscle tissue.10, 12, 24 The 
averaging effect of studying a heterogeneous population, such as this, may mask the 
contribution of individual smooth muscle cells (SMCs) with unique SM-MHC isoform expression 
levels. To more directly address the possible unique physiological properties of the SM-MHC 
isoforms, we examined the correlation between the relative expression of SM1 and SM2 and 
the contractile properties of isolated SMCs. The experimental design avoids two of the 
potential pitfalls of previous studies. First, by making both the unloaded shortening and reverse 
transcription-polymerase chain reaction (RT-PCR) measurements in the same single SMC, one 
avoids problems of cellular heterogeneity and averaging. Second, with the use of an intact 
three-dimensional cell, intermolecular interactions that may be of significance are more likely 
to remain intact. The results of this study suggest that SM-MHC expression does not affect the 
unloaded shortening of isolated individual SMCs. Significant correlations between SM-MHC 
expression and minimum cell length were detected in this study. One possible explanation for 
this relationship between minimum length and isoform expression is that the SM1 and SM2 
isoforms differentially affect myosin filament length and thus alter the range of shortening 
possible in these cells. 
METHODS 
General. 
New Zealand White rabbits were killed by CO2 asphyxiation. Vascular tissues (aorta, carotid) 
were removed, cleaned of blood, adipose, and loose connective tissue, and stored in 
physiological salt solution [PSS; in mM: 140 NaCl, 4.7 KCl, 1.2 Na2HPO4, 1.2 MgSO4, 1.6 CaCl2, 
5.6 glucose, 0.02 EDTA, and 2.0 3-(N-morpholino)propanesulfonic acid (MOPS), pH 7.4] at 4°C 
until processed. 
Cell isolation. 
Individual cells were isolated from carotid or aortic arteries with methods modified from Driska 
and Porter (7). Briefly, the vessel is bisected longitudinally and incubated in Ca2+-free PSS (in 
mM: 140 NaCl, 4.7 KCl, 1.2 Na2HPO4, 2.4 MgSO4, 0.0 CaCl2, 5.6 glucose, 0.02 EDTA, and 2.0 
MOPS, pH 7.4) 15 min before digestion to reduce activation due to mechanical perturbation 
during isolation. The vessel was then cut transversely into 1- to 3-mm strips, consistent with the 
orientation of the long axis of the SMCs. These strips were placed in prewarmed (37°C) Ca2+-
free PSS containing papain (20 U/ml) in a shaking water bath (50 cycles/min) for 10 min. After 
digestion, the strips were rinsed with fresh Ca2+-free PSS and then the medial layer was 
carefully teased apart, liberating single SMCs. 
Single cell contractions. 
Mechanical measurements were performed in a flow-through chamber consisting of a 
depression slide with three inputs and one output. The concave depression on the slide was 
surrounded by a wax ring to prevent fluid dispersal during movement of micropipettes within 
the solution for cell manipulation. The gravity-feed flow through the input tubes was monitored 
by inclusion of fast green (0.002% wt/vol) in the perfusion solutions. Outflow from the 
perfusion chamber was controlled by a peristaltic pump (Rabbit Miniplus 2, Rainin Instrument, 
Emeryville, CA). Output was matched to input by adjusting the speed of the peristaltic pump so 
that the chamber fluid meniscus remained at a constant level. 
Single SMCs were isolated from vascular tissue (aorta and carotid) by the methods detailed 
in Cell isolation. The SMCs were transferred from coated glass isolation dishes (Sigmacote, 
Sigma, St. Louis, MO; Slickcoat, Intermountain Scientific, Kaysville, UT) via wide-bore pipettes to 
the depression slides. Cells were allowed to settle to the bottom of the slide (5 min) before 
solution exchange from Ca2+-free PSS to relaxing buffer (pCa 9.0) [relaxing buffer contained (in 
mM) 14.5 creatine phosphate, 7 ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic 
acid (EGTA), 20 imidazole, 1 free Mg2+, 4 free MgATP, 5.42 MgCl2, 79.16 KCl, and 4.74 ATP and 
16.33 μM CaCl2, pH 7.0]. Once cells were in the relaxing buffer, permeabilization of the SMC 
membrane was accomplished by one of three methods:1) 5-min incubation in relaxing buffer + 
250 hemolytic U/ml staphylococcal α-toxin (α-toxin)4,2) 10-min incubation in relaxing buffer + 
250 U/ml α-toxin, or 3) 10-min incubation in relaxing buffer + 35 μg/ml saponin.38 After 
permeabilization, all SMCs were washed with relaxing buffer (2 min). 
After washing was completed, a permeabilized SMC was selected on the basis of morphology9 
and birefringence of the cell membrane using phase-contrast microscopy. The cell was attached 
to a small bore (1- to 3-μm tip) glass micropipette by close apposition of the pipette tip and 
gentle suction. Once attached, the SMC was lifted off the chamber floor, to ensure absence of 
adhesion, and stimulated with an activation cocktail consisting of 1 μM phenylephrine and 1 
μM histamine in activating buffer (pCa 6.0) [activating buffer contained (in mM) 14.5 creatine 
phosphate, 7 EGTA, 20 imidazole, 1 free Mg2+, 4 free MgATP, 5.31 MgCl2, 68.55 KCl, 4.79 ATP, 
and 4.91 CaCl2, pH 7.0]. 
Permeabilized cells were also activated with two different Ca2+ concentrations without the 
other agonists to determine if the cells were being fully activated. No differences were 
observed with 10−5 M Ca2+, 10−6 M Ca2+, or 10−6 M Ca2+ with the two agonists. All cells reported 
in this study were activated with the full cocktail (10−6 M Ca2+, 1 μM phenylephrine, and 1 μM 
histamine). As an additional control, five cells were activated with the activating cocktail that 
also included 1 μM okadaic acid, a myosin light chain (MLC) phosphatase inhibitor.3 
Cell length data acquisition. 
Before and throughout the single SMC contraction, cell length was continuously monitored by a 
charge-coupled device (CCD) camera (XC-75, Sony, Park Ridge, NJ) attached to an inverted 
microscope (×320; Fluovert, Leitz, Overland Park, KS). The output from the CCD camera was 
recorded by a video recorder (EV-S3000, Sony, Park Ridge, NJ) on 8-mm videotape. SMC images 
from the 8-mm tape were captured by a frame grabber (Data Translation, Marlborough, MA) in 
conjunction with NIH Image software (version 1.31; National Institutes of Health, Bethesda, 
MD) at regular intervals encompassing the SMC contraction. Image analyses were performed 
using NIH Image software (version 1.59). Each frame of the cell from successive time points was 
brought up on the computer screen. The ends of the cell were identified on the frame. Using 
the mouse and starting at one end of the cell, we marked the midpoint of the cell’s width along 
its entire length at 5- to 10-μm intervals (see Fig. 3). The length of the line connecting these 
points gave total cell length for each frame. This method gives an accurate measurement of cell 
length independent of linearity. 
Untethered velocity measurements from single SMCs. 
Video images from the CCD camera were recorded on a videocassette recorder, digitized, 
imported into a personal computer, and analyzed with respect to length over a discrete time 
frame using NIH Image software (version 1.59). Of the 53 cells examined, 28 exhibited the 
following criteria: 1) characteristic morphology of contracted SMCs (i.e., evaginations in cell 
membrane postcontraction)9 and2) a smooth sigmoidal decrease in length over time, indicating 
unconstrained contraction within the plane of focus of the microscope. Unloaded shortening 
velocity was taken from the steepest slope of a plot of length vs. time (see Fig. 2) for these 28 
cells and plotted against their SM2-to-SM1 mRNA ratio. After its contraction, each cell from 
which mechanical measurements were made was transferred to a microcentrifuge tube so that 
the SM2-to-SM1 mRNA ratio could be determined. This allowed both the mechanical 
measurements and the RT-PCR to be performed on the same cell. 
RT-PCR. 
The methods used are those of Meer and Eddinger.24 Briefly, single SMCs were transferred to a 
microcentrifuge tube via a micropipette and lysed by a freeze/thaw cycle. Ten microliters of RT 
reaction mix [5× RT buffer (US Biochemical, Cleveland, OH), 0.02 μg/μl oligo(dT) (Promega, 
Madison, WI), 2 U/μl RNasin (Promega), 0.1 μg/μl acetylated bovine serum albumin, 500 μM 
dNTP, 1.23 mM dithiothreitol, and 10 U/μl Moloney murine leukemia virus-RT (US 
Biochemical)] were added to each tube and incubated at 37°C for 2 h. PCR reaction mix 
[TaqDNA polymerase 10× reaction buffer (Promega), 1.8 mM MgCl2, 50 μM dNTP, 1 μM 5′ 
primer, 1 μM 3′ primer, and 1 unitTaq polymerase (Promega)] was added to each tube to a final 
volume of 50 μl. The primers used corresponded to rabbit smooth muscle myosin1 (nucleotide 
positions 5627–5646 and 5917–5898; Operon, Alameda, CA). Sixty cycles of amplification were 
performed, using the following temperature profile: 94°C (1 min, 30 s), 55°C (2 min), and 72°C 
(3 min). An additional unit of Taqpolymerase was added after the first 30 PCR cycles. Controls 
performed indicate the SM2-to-SM1 mRNA ratio is an excellent predictor of the SM2-to-SM1 
protein ratio (r = 0.92) and that these methods are reliable, reproducible, sensitive, and 
accurate.24 
Electrophoresis and densitometry. 
PCR products were separated by electrophoresis on 8% acrylamide gels11 and visualized under 
ultraviolet light after staining with ethidium bromide (1 μg/ml). Band intensity was quantitated 
by image analysis of gel photographs using Ambis 2000 software (Ambis, San Diego, CA). 
RESULTS 
Assessment of the functional significance of the differential expression of SM1 and SM2 MHC 
isoforms was addressed by examining the contractile properties of isolated SMCs from which 
the relative levels of SM1 and SM2 mRNA were determined by RT-PCR. We have previously 
shown that RT-PCR is an accurate and precise method of measuring the relative levels of SM1 
and SM2 mRNA and that the relative levels of SM2/SM1 mRNA correlate well with the relative 
amounts of SM2/SM1 protein.24 SM2-to-SM1 mRNA ratios exhibited by single SMCs in this 
study ranged from 0.07–0.60 [n = 28, mean value of 0.33 ± 0.16 (SD)]. An example of the PCR 
products amplified from single arterial SMCs is shown in Fig.1. Table 1 gives the raw values for 
the bands shown in Fig. 1 and the SM2-to-SM1 ratio for each of the seven cells. 
 
 
Fig. 1. 
Single smooth muscle cell (SMC) SM2/SM1 polymerase chain reaction (PCR) products. Individual SMCs 
were utilized for reverse transcription (RT)-PCR, as described in methods, to correlate contractile 
properties of individual cells with their myosin heavy chain expression profile. RT-PCR products from 7 
single cells isolated from the same rabbit aorta are shown in lanes 3–9. SM2-to-SM1 ratios for the 7 cells 
shown range from a high of 0.55 in lane 4 to a low of 0.03 in lane 7. A 123-base pair (bp) DNA ladder was 
run in lane 1; 123-, 246-, and 492-bp bands are shown. Lane 2 contains the same RT-PCR reaction mix 
used on the 7 cells; however, mRNA was omitted. 
 
Table 1. Raw data and ratios for SM2/SM1 for single smooth muscle cells shown in Fig. 1 
Lane SM2 SM1 SM2-to-SM1 Ratio 
3 15,015 41,430 0.36 
4 21,841 38,225 0.55 
5 22,336 44,796 0.50 
6 3,404 47,897 0.07 
7 1,864 60,025 0.03 
8 15,261 37,569 0.41 
9 17,246 30,911 0.46 
Viability of isolated SMCs was determined by two criteria:1) a smooth, bright plasma 
membrane when viewed with phase-contrast microscopy as described by Driska and Porter (7) 
and Fay and Delise9 and2) a smooth sigmoidal contraction after exposure to the activating 
cocktail (Fig. 2), indicating an unconstrained contraction. Because we are unaware of a method 
capable of determining the phosphorylation state of the 20-kDa MLCs in single SMCs, we 
adopted a stimulation protocol that would theoretically produce maximal contractions in 
isolated SMCs. Permeabilized single SMCs were exposed to a cocktail containing 1 μM free 
Ca2+ (pCa 6.0), 1 μM phenylephrine, and 1 μM histamine. Individually, each of these compounds 
at these concentrations should produce a maximal contraction of SMCs, as they do at the tissue 
level. In concert, these substances should alleviate any intercellular differences in second 
messenger systems by direct activation as well as multiple receptor-operated mechanisms. No 
observable differences were noted between permeabilized cells activated with 10−5 M Ca2+, 
10−6 M Ca2+, or 10−6 M Ca2+ with 1 μM phenylephrine and histamine. An example of a typical 
single vascular SMC contraction is shown in Fig. 3. In addition, five cells were activated with the 
activating cocktail, which included 1.0 μM okadaic acid. These cells shortened at rates [n = 5, 
average velocity = 1.1 ± 0.66 (SD) μm/s, minimum value = 0.44, maximum value = 1.84] that 
were not significantly different from cells activated without the okadaic acid (see below). 
 
Fig. 2. 
Measurement of single SMC length during untethered shortening. Record of the optical measurement of 
the length of an α-toxin-permeabilized (5 min) SMC following activation with Ca2+ (pCa 6.0), 
phenylephrine (1 μM), and histamine (1 μM) is shown. Cell was suspended from a micropipette and was 
not in contact with the bottom of the chamber. 
 
Fig. 3. 
Contraction of a single SMC. A temporal series of digitized images of a permeabilized SMC contracting in 
response to exposure to an activating solution containing Ca2+ (pCa 6.0), phenylephrine (1 μM), and 
histamine (1 μM) is shown. Cell length in A, before activation, was 123 μm. Time forA–Dwas 0, 14, 32, 
and 50 s, respectively. A segmented line drawn through the middle of the cell from end to end shows 
the measured length for each cell. 
To assess the efficacy of isolated SMC permeabilization, three different permeabilization 
protocols were utilized in this study. The first method was modified from Brozovich (4), in 
which isolated SMCs are exposed to staphylococcal α-toxin (250 hemolytic U/ml) for 5 min in a 
low-Ca2+ physiological buffer. Thirteen of 28 viable cells were permeabilized in this fashion. The 
average velocity of these cells was 1.10 ± 0.58 (SD) μm/s (n = 13, minimum value = 0.26 μm/s, 
maximum value = 1.85 μm/s). Permeabilization of the SMC plasma membrane was confirmed 
via the use of trypan blue dye. Trypan blue is excluded from intact cells. Two other 
permeabilization methods were utilized to confirm that the SMCs were being adequately 
permeabilized to assure maximum activation. Seven SMCs were permeabilized with α-toxin 
(250 U/ml) for twice the previous exposure time (10 min); the peak velocities of these cells 
were not significantly different compared with the cells exposed to α-toxin for 5 min [paired 
Student’s t-test,P < 0.05,n = 7, mean value of 1.12 ± 0.58 (SD) μm/s, minimum = 0.47 μm/s, 
maximum = 2.06 μm/s]. Because the two α-toxin data sets were overlapping, even though the 
permeabilization protocol was slightly different, the sets were combined for data analyses and 
comparisons. The final permeabilization protocol was modified from Walsh et al.,38 which 
involved a 15-min permeabilization with saponin (35 μg/ml). Due to basic differences in the 
mechanisms of permeation between α-toxin and saponin and a slightly lower, but not 
significantly different, average peak velocity (0.80 μm/s), the saponin-permeabilized cells were 
regarded as a separate data set. 
The 28 viable, permeabilized cells were examined with respect to initial length (before 
activation), final length (minimum length), peak unloaded shortening (maximum rate of 
shortening), total length change (initial length − minimum length) and SM2/SM1 mRNA 
expression levels. The mechanical and the molecular measurements were both performed on 
the same cells. The various physical measurements were all correlated with the SM2/SM1 
mRNA level of the individual cells. Data from cells permeabilized with staphylococcal α-toxin 
are shown in Fig. 4,A–D. Data from cells permeabilized with saponin are shown in Fig.5,A–D. 
Data from correlational analysis with SM2-to-SM1 mRNA ratio using linear regression (least-
squares method) are recorded in Table2; t-tests were performed on the various coefficients of 
correlation to determine if the null hypothesis could be rejected. At theP < 0.05 level withn − 2 
degrees of freedom, the null hypothesis was rejected in the case of the relationship between 
the SM2-to-SM1 ratio and final cell length (both α-toxin- and saponin-permeabilized cells), 
making this correlation significant. All the other correlations shown in Figs. 4 and 5 are not 
significant. 
 Fig. 4. 
Velocity and length changes in α-toxin-permeabilized SMCs during untethered shortening and their 
correlations to the SM2-to-SM1 ratio. Twenty (total) single SMCs isolated from rabbit vasculature (aorta 
or carotid) and permeabilized with α-toxin (250 hemolytic U/ml) were activated with activating solution 
(seemethods; pCa 6.0, 1 μM phenylephrine, 1 μM histamine) while suspended in solution from one end 
by a suction micropipette. Cell length and velocity of shortening were measured and compared with the 
RT-PCR-generated SM2-to-SM1 mRNA ratio. A: correlation between maximal shortening velocity (Vmax) 
and SM2/SM1. Correlations between initial length (B), final length (C), and total change in length (D) 
with SM2-to-SM1 ratio are also shown. Line through data forA–Dis best fit with r value given (top right). 
C, carotid cells. All other cells were from the aorta. 
 Fig. 5. 
Velocity and length changes in saponin-permeabilized SMCs during untethered shortening and their 
correlations to SM2/SM1. Eight single SMCs isolated from rabbit aorta and permeabilized with saponin 
(35 μg/ml) were activated with activating solution (seemethods; pCa 6.0, 1 μM phenylephrine, 1 μM 
histamine) while suspended in solution from one end by a suction micropipette. Cell length and velocity 
of shortening were measured and compared with the RT-PCR-generated SM2-to-SM1 mRNA ratio. A: 
correlation betweenVmax and SM2/SM1. Correlations between initial length (B), final length (C), and total 
change in length (D) with SM2-to-SM1 ratio are also shown. Line through data forA–Dis best fit 
with rvalue given (top right). 
Table 2. Correlations of contraction characteristics with SM2-to-SM1 ratio 
Variable Correlated with SM2-to-SM1 Ratio rValue, α-toxin treated (n = 20) r Value, saponin-treated (n = 8) 
Peak velocity, μm/s 0.03 0.27 
Initial length, μm 0.39 0.14 
Final length, μm 0.72† 0.78* 
Length change, μm 0.13 0.26 
*Significant at P < 0.05. 
†Significant atP < 0.01. 
DISCUSSION 
The physiological significance of the SM1 and SM2 SM-MHC tail isoforms was investigated in 
this study by examining the relationship between SM2/SM1 mRNA expression levels and the 
characteristics of untethered shortening in contracting single SMCs. Untethered shortening 
velocity measurements of SMCs suspended in solution provide the best approximation of 
shortening under zero load. The use of micromolar free Ca2+ to activate isolated, permeabilized 
SMCs exceeds the reported requirement of 0.36 μM Ca2+ for maximal contractile response in 
isolated, permeabilized feline esophageal SMCs.34 The fact that three different permeabilization 
protocols yield unloaded shortening values that are not significantly different (P < 0.05) also 
suggests that these are maximal contraction rates. The intact isolated SMCs are not activated 
by external Ca2+(1.6 mM), and the permeabilized isolated SMCs do not contract unless they are 
exposed to Ca2+. 
Because we are unaware of a method for quantitation of MLC phosphorylation at the single cell 
level, we chose to achieve maximum activation by direct (with μM concentrations of Ca2+) and 
indirect (with μM concentrations of phenylephrine and histamine) mechanisms to ensure this 
result. To further validate this assumption, five cells were activated with the same activating 
cocktail solution to which 1.0 μM okadaic acid was added. At this concentration, okadaic acid 
has been reported to be a PP-1 protein phosphatase-type inhibitor, which includes the MLC 
phosphatase.3 No differences in mechanical responses were observed for cells activated with or 
without the okadaic acid included in the activating cocktail, suggesting that we have maximally 
activated these cells and differences in shortening velocities are not due to differences in MLC 
phosphorylation. 
The methods used in this study significantly increase the types of questions that may be 
addressed relative to previous experimental designs. As has been previously shown,24 there is 
extensive heterogeneity with regard to the SM-MHC tail isoforms between individual SMCs in 
the same tissue. Thus multicellular experiments are limited to providing averaged information 
from a wide range of cells exhibiting different levels of contractile protein isoforms. ATPase 
measurements and in vitro motility measurements are done outside of the native structural 
organization of the cell. Thus possible intermolecular effects may not be examined. The 
methods used in this study allow mechanical measurements to be made on a three-
dimensionally intact cell and to measure the relative amounts of various protein isoforms from 
the same cell (via mRNA levels). This avoids potential problems of intercellular variability, while 
keeping the three-dimensional structure and intracellular protein arrangement intact. 
Previous attempts with multicellular preparations have failed to establish a definitive 
relationship between SM2/SM1 content and velocity in smooth muscles. Sparrow et al.35 and 
Hewett et al.14 have shown small positive correlations between SM1 MHC content andVmax in 
rat myometrial muscle. However, Morano et al.25 have shownVmax to correlate with LC17a 
content and not SM1 or SM2 content in the same tissue. Cai et al.5 have shown that incubation 
with synthetic peptide identical to a portion of the nonhelical tail unique to SM1 significantly 
reducedVmax in permeabilized smooth muscles. This last finding is in opposition to the earlier 
findings that SM1 exhibits a positive correlation withVmax.14, 35 This study shows no significant 
correlation between SM2/SM1 mRNA expression and unloaded shortening at the single SMC 
level (Figs.4A and5A; Table 2). These data support the conclusion of Morano et al.25 that in 
uterine tissueVmax does not correlate with SM-MHC tail isoform content. This finding is also in 
agreement with data showing no difference in the rate of actin filament sliding in the in vitro 
motility assay by bovine aortic SM1 and SM2.20 This result extends the previous data20 by 
examining the myosin isoforms in their native environment, where intermolecular interactions 
can still occur but intercellular heterogeneity is not a problem. 
The best correlation between SM2/SM1 isoform content and the physical characteristics of 
vascular SMCs during untethered shortening was with the final postcontraction length of the 
SMC (Figs.4C and5C, Table 1,r = 0.72 for α-toxin-permeabilized cells and r = 0.78 for saponin-
permeabilized cells). Thus an increased SM2 isoform expression appears to impart to the SMC 
the ability to attain a shorter final length following maximal contraction. The difference region 
between SM1 and SM2 occurs at the 3′ end of the myosin molecule, an area of the MHC that 
has been shown to be very important in the process of myosin filament formation. Proteolytic 
cleavage,15, 31 antibody binding,6 and phosphorylation6a, 17, 21–23 of this region influence both 
myosin filament nucleation and structure. The synthetic myosin filaments formed from 
mixtures of myosin isoforms isolated from smooth and skeletal muscles exhibit lengths 
intermediate between the longer skeletal filaments and the shorter smooth filaments.16, 28, 37 
Experiments performed at near physiological pH (pH 6.5–7.0) generated “hybrid” filaments with 
a unimodal length distribution, with shorter average lengths as the percentage of smooth or 
nonmuscle myosin increased.16, 28, 37 The unimodal nature of these length distributions indicates 
the presence of a single population of filaments composed of both smooth or nonmuscle 
myosin isoforms and skeletal myosin. Another indication of the uniform incorporation of both 
smooth and skeletal myosins into these hybrid filaments is the fact that paracrystals composed 
of these filaments exhibit a single axial repeat pattern.37 
If smooth and skeletal myosins can copolymerize to generate myosin filaments with varying 
lengths, then it is also possible that copolymerization of the SM-MHC isoforms, SM1 and SM2, 
may generate filaments with varying lengths. The incorporation of increasing amounts of SM2 
into cellular myosin filaments may reduce the lengths of these filaments. These shorter SM2-
containing filaments may allow force generation at shorter lengths, extending the length-
tension curve of cells containing SM2 to the left and thereby allowing SMCs with SM2 to attain 
shorter final lengths. Although the possibility of shorter SM1/SM2 hybrid filaments may not be 
the only mechanism responsible for the shorter minimal lengths of SMCs with higher levels of 
SM2 expression, it is certainly plausible. We are not proposing that any given myosin filament 
can span the entire length or width of the SMC. However, several of these hybrid filaments in 
series may allow increased force production as the SMC approaches its minimum length due to 
reduced steric hindrance. This could result from compression of the intracellular contents and 
interaction with dense bodies and/or intermediate filaments. Another factor that may be 
playing a role is the proposed remodeling of the contractile proteins of SMCs at shorter 
lengths.13 It is possible that at shorter initial lengths the cytoskeleton is remodeled to allow 
maximum shortening when activated; however, once activated and under strain the contractile 
elements cannot rearrange to optimize shortening. If this applies to the initial lengths of the 
SMCs in this study, the contribution to final length would be small, as the correlation between 
SM2/SM1 expression and initial length was not significant at the 5% level (Table 2). Our current 
model for the effect of SM2/SM1 expression on the minimum length an SMC can attain 
following untethered shortening is that hybrid SM2/SM1 myosin filaments are structurally 
different from SM1 myosin filaments, thereby permitting the greater extent of shortening 
exhibited by SMCs with higher levels of SM2 expression. 
There are other possible explanations as well. Myosin filament stability may be affected by the 
amount of SM1 and SM2 MHC they contain. This could allow some filaments to disassemble 
and reassemble at shorter lengths and thus increase total cell shortening. These filaments may 
also have different affinities for other cytoskeletal proteins that provide for the scaffolding of 
cells. A third possibility includes regional localization and/or regulation of these filaments either 
via phosphorylation or other mechanisms that could affect cell shortening. Further work is 
needed to test these hypotheses. 
We have reported previously24 that there is extreme heterogeneity in the ratio of the SM2/SM1 
MHC tail isoforms present in single cells from a given vessel. Here, we report that this 
difference does not correlate with unloaded shortening velocity but does correlate with how 
much the cell shortens. These results, in light of reports of regional localization of unique cell 
populations,10, 12 suggest unique functional roles for cells with different levels of SM1 and SM2 
expression. During vascular constriction, the adventitial portion of the smooth muscle layer 
contracts to a greater extent than the intimal portion, resulting in the formation of periluminal 
ridges. This folding of the intimal regions of the vascular wall allows the maintenance of a 
circular luminal cross section and continuous blood flow during vasoconstriction.33 If SM2 
expression is higher in SMCs localized near the adventitial aspect of the vascular smooth muscle 
layer, as suggested by Frid et al.,10 then the shorter final lengths these cells can attain may play 
a role in the disproportionate shortening of this layer with respect to the luminal aspect.33 
Clearly, there are other possible explanations for the results reported in this paper. Further use 
of these single cell methods in conjunction with structural studies (i.e., immunoelectron 
microscopy, in situ hybridization) should provide answers to the functional significance of these 
and other contractile protein isoforms in SMCs. 
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